Science

May 6, 2025, 16:09

Myeloma Paper of the Day, May 6th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Extramedullary disease (PFS was 24.2 months without EMD vs. 9.0 months with) but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in myeloma; about half of relapses post-CAR T had EMD.”

Title: Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma

Authors: Darren Pan, Tarek H. Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier, Joshua Richter, Samir Parekh, Sundar Jagannath, Adriana C. Rossi, Larysa J. Sanchez, Santiago Thibaud, Cesar Rodriguez, Hearn J. Cho and Shambavi Richard.

Read the Full Article on Bone Marrow Transplantation.

More posts featuring Robert Orlowski.

Adriana C. Rossi Bone Marrow Transplantation cancer CAR T-cell therapy Cesar Rodriguez Darren Pan Erin Moshier Hearn J. Cho Joshua Richter Larysa J. Sanchez multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Samir Parekh Santiago Thibaud Shambavi Richard Sundar Jagannath Tarek H. Mouhieddine Tianxiang Sheng Weijia Fu

Does Plastic Cause Cancer? Myths and Facts

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon